Search - tctmd.com

Displaying 141 - 160 of 527

Sort: Relevancy | Date

Presentation TCT 2022

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

Presenter: Tijn Jansen

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

Presentation TCT 2022

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Presenter: Shinichiro Masuda

September 19, 2022

Presentation TCT 2022

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

Presenter: Charles J. Davidson

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

Presentation TCT 2022

Clinical Trial Updates: A Selective Review of What All Operators Should Know

Presenter: John Carroll

September 18, 2022

Presentation TCT 2022

Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective

Presenter: Patrick O'Gara

September 18, 2022

Presentation TCT 2022

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

Presenter: C. Michael Gibson

September 18, 2022

News Conference News TCT 2022

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

Todd Neale

September 18, 2022

Presentation TCT 2022

TCT 7: Invasive Versus Conservative Strategy in Elderly Patients With Non-ST Elevation Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials

Presenter: Mahmoud Khalil

September 18, 2022

Presentation TCT 2022

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Presenter: Clyde Yancy

September 18, 2022

Presentation TCT 2022

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

Presenter: Philippe Genereux

September 18, 2022

Presentation TCT 2022

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

Presenter: SHIGETAKA KAGEYAMA

September 18, 2022

$TCT 137: Contribution of plaque composition to the extent of plaque fracture and dissection following drug-coated balloon angioplasty in de novo small vessel disease: an interim report of the TRANSFORM-I trial$

Presentation TCT 2022

TCT 137: Contribution of plaque composition to the extent of plaque fracture and dissection following drug-coated balloon angioplasty in de novo small vessel disease: an interim report of the TRANSFORM-I trial

Presenter: Patrick Serruys

September 18, 2022

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

Presentation TCT 2022

TCT 145: Impact of Technique on Provisional Bifurcation Stent Outcomes in the European Bifurcation Club Left Main Coronary Trial

Presenter: Sandeep Arunothayaraj

September 18, 2022

Presentation TCT 2022

Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL)

Presenter: Sanjit Jolly

September 18, 2022

Presentation TCT 2022

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Presenter: Azeem Latib

September 18, 2022

Presentation TCT 2022

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Presenter: ShaoLiang Chen

September 18, 2022

Presentation TCT 2022

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Presenter: Deepak Bhatt

September 18, 2022

Advertisement

TCT 305: The effect of diltiazem versus placebo on microvascular dysfunction assessed by serial continuous thermodilution measurements: results of the EDIT-CMD trial.

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

TCT 304: Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Clinical Trial Updates: A Selective Review of What All Operators Should Know

Clinical Implications of RADIANCE II and Recent Renal Denervation Trials: A Clinician’s Perspective

Transformative Changes in Clinical Research: A Futurist’s Viewpoint

RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP

TCT 7: Invasive Versus Conservative Strategy in Elderly Patients With Non-ST Elevation Myocardial Infarction: A Meta-analysis of Randomized Controlled Trials

Health Equity Issues in Clinical Trials: Can We Accelerate Progress?

Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results From the PARTNER Trials

TCT 295: Periprocedural Angiography-Derived Index of Microvascular Resistance in Patients With Multivessel Disease: Perspective From Multivessel TALENT Trial

TCT 137: Contribution of plaque composition to the extent of plaque fracture and dissection following drug-coated balloon angioplasty in de novo small vessel disease: an interim report of the TRANSFORM-I trial

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

TCT 145: Impact of Technique on Provisional Bifurcation Stent Outcomes in the European Bifurcation Club Left Main Coronary Trial

Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL)

The Future of Sirolimus Coated Balloons: a look at the design of IDE clinical trials

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial

Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-Year Follow-up of the SYMPLICITY HTN-3 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content